DIAGNOSTIC AND THERAPEUTIC USES OF SOLUBLE FC-EPSILON RECEPTOR I FOR IGE-MEDIATED DISORDERS
摘要
<p>The present disclosure is based in part on the finding that sFceRI is a novel biomarker for IgE-mediated disorders. Methods for diagnosing, treating and/or monitoring IgE- mediated disorders are also described. The disclosure further provides assays to detect sFceRI in a sample.</p>
申请公布号
WO2011034597(A1)
申请公布日期
2011.03.24
申请号
WO2010US02538
申请日期
2010.09.17
申请人
CHILDREN'S MEDICAL CENTER CORPORATION;FIEBIGER, ELISABETH-EDDA;LENCER, WAYNE, I.
